<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01982006</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2012/23</org_study_id>
    <nct_id>NCT01982006</nct_id>
  </id_info>
  <brief_title>Economic Evaluation of Femtosecond Laser Assisted Cataract Surgery</brief_title>
  <acronym>FEMCAT</acronym>
  <official_title>Impact Médico-Economique de la Chirurgie de la cATaracte au Laser Femtoseconde</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cataract is the leading cause of blindness worldwide and cataract surgery is the most
      frequent surgery performed in France. A new technology, the femtosecond laser-assisted
      cataract surgery, has to be compared with phacoemulsification alone, the conventional
      cataract surgery, to determine the economic impact of femtosecond laser-assisted process for
      the French healthcare insurance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An estimated 700,000 cataract procedures are performed every year in France, with this amount
      of surgeries predicted to climb as the population there, as well as around the world, ages.
      Currently, phacoemulsification alone is the conventional cataract surgery. The femtosecond
      laser-assisted cataract surgery has to be compared with the standard process to provide
      information on how it could benefit the patient population treated every year for cataract
      surgery. This economic study has received a grant from the French Ministry of Health to
      evaluate the economic impact of femtosecond laser-assisted process for the French healthcare
      system. For this goal, this prospective, randomized, parallel, multicenter and simple blind
      study will determine the incremental cost/effectiveness ratio for femtosecond laser-assisted
      process versus phacoemulsification surgery. Visual acuity results and intraoperative or
      postoperative complication rate will be compared between both groups. The learning curve of
      the femtosecond laser assisted cataract surgery will be also evaluated for each surgeon
      involved in the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 9, 2013</start_date>
  <completion_date type="Actual">December 15, 2016</completion_date>
  <primary_completion_date type="Actual">December 15, 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incremental Cost/effectiveness ratio defined as cost per incremental therapeutic success.</measure>
    <time_frame>3 months after inclusion</time_frame>
    <description>Therapeutic success will be defined by the association of the following criterion:
No severe intraoperative or postoperative complications,
Best Corrected Visual Acuity of 0 LogMAR,
A refractive error inferior or equal to 0.75 diopter,
Corneal surgically-induced astigmatism inferior or equal to 0.5 diopter and a postoperative change of astigmatism axis inferior or equal to 20°.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Before surgery (From day -8 to day -1) and months 1, 3 and 12 after surgery</time_frame>
    <description>Quality of life evaluation using Visual Function 14 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Learning curve of the femtosecond laser-assisted cataract surgery</measure>
    <time_frame>End of research (Month 12)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall costs of cataract surgery in both arms from the hospital perspective</measure>
    <time_frame>End of research (Month 12)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental cost - Utility ratio defined as incremental Cost/QALY (Quality Adjusted Life Year) for healthcare insurance in both arms</measure>
    <time_frame>12 months after inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>No severe intraoperative or postoperative complications</measure>
    <time_frame>3 months after inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Best Corrected Visual Acuity of 0 LogMAR</measure>
    <time_frame>3 months after inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Refractive error inferior or equal to 0.75 diopter</measure>
    <time_frame>3 months after inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal surgically-induced astigmatism inferior or equal to 0.5 diopter and a postoperative change of astigmatism axis inferior or equal to 20°</measure>
    <time_frame>3 months after inclusion</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">920</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Phaco</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cataract surgery by phacoemulsification</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Femto</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Corneal incision, anterior capsulorhexis and lens fragmentation by femtosecond laser</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cataract surgery with Phacoemulsification</intervention_name>
    <description>Each patients randomized in the phaco arm will undergo a conventional cataract surgery.
Corneal incisions will be manually performed using the same calibrated blade and at the same location for all procedures of one surgeon.
Phacoemulsification machine used to perform cataract surgery in each center will be the same for all patients included in the center. The IOL (IntraOcular Lens) used in each center will be the same for all patients treated in the center.</description>
    <arm_group_label>Phaco</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Femtosecond laser-assisted cataract surgery</intervention_name>
    <description>Each patients randomized in the femto arm will undergo a femtosecond laser assisted cataract surgery.
Corneal incisions will be performed by the laser. Number, size and location of the incisions must be the same than in the phaco arm for all patients treated by one surgeon.
Phacoemulsification machine used to remove the liquefied lens will be the same than in the phaco arm The IOL used in each center will be the same than in the phaco arm</description>
    <arm_group_label>Femto</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cataract with impaired visual acuity (&gt; or equal +0.3 LogMAR) or with cataract-related
             visual symptoms (Halos, Monocular diplopia, glare)

          -  French healthcare insurance beneficiary

        Exclusion Criteria:

          -  Pupil size lower than 6mm

          -  Iris constriction

          -  Iris synechiae

          -  Preoperative zonular instability or crystalline lens subluxation

          -  Obstructive Corneal scars

          -  Obstructive pterygion

          -  Axial length &lt;20.5 mm

          -  Corneal astigmatism &gt;1.5 diopters

          -  Fuchs corneal dystrophy

          -  History of Central retinal vein or artery occlusion

          -  History of uveitis

          -  History of optic nerve head neuropathy except glaucoma

          -  Progressive glaucoma

          -  Nystagmus

          -  Uncontrolled diabetes mellitus

          -  General history of dementia or psychotic disorders

          -  Pregnancy, breast feeding

          -  General medications: Alpha-blockers, Carbonic anhydrase inhibitors
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cédric SCHWEITZER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Bordeaux, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>BENARD Antoine, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Bordeaux, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospices Civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69317</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75679</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Tours</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Abraham AG, Condon NG, West Gower E. The new epidemiology of cataract. Ophthalmol Clin North Am. 2006 Dec;19(4):415-25. Review.</citation>
    <PMID>17067897</PMID>
  </reference>
  <reference>
    <citation>Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004 Nov;82(11):844-51. Epub 2004 Dec 14.</citation>
    <PMID>15640920</PMID>
  </reference>
  <reference>
    <citation>Lamoureux EL, Fenwick E, Pesudovs K, Tan D. The impact of cataract surgery on quality of life. Curr Opin Ophthalmol. 2011 Jan;22(1):19-27. doi: 10.1097/ICU.0b013e3283414284. Review.</citation>
    <PMID>21088580</PMID>
  </reference>
  <reference>
    <citation>Høvding G, Natvik C, Sletteberg O. The refractive error after implantation of a posterior chamber intraocular lens. The accuracy of IOL power calculation in a hospital practice. Acta Ophthalmol (Copenh). 1994 Oct;72(5):612-6.</citation>
    <PMID>7887161</PMID>
  </reference>
  <reference>
    <citation>Norrby S. Sources of error in intraocular lens power calculation. J Cataract Refract Surg. 2008 Mar;34(3):368-76. doi: 10.1016/j.jcrs.2007.10.031.</citation>
    <PMID>18299059</PMID>
  </reference>
  <reference>
    <citation>Norregaard JC, Thoning H, Bernth-Petersen P, Andersen TF, Javitt JC, Anderson GF. Risk of endophthalmitis after cataract extraction: results from the International Cataract Surgery Outcomes study. Br J Ophthalmol. 1997 Feb;81(2):102-6.</citation>
    <PMID>9059242</PMID>
  </reference>
  <reference>
    <citation>Powell SK, Olson RJ. Incidence of retinal detachment after cataract surgery and neodymium: YAG laser capsulotomy. J Cataract Refract Surg. 1995 Mar;21(2):132-5.</citation>
    <PMID>7791051</PMID>
  </reference>
  <reference>
    <citation>Norregaard JC, Thoning H, Andersen TF, Bernth-Petersen P, Javitt JC, Anderson GF. Risk of retinal detachment following cataract extraction: results from the International Cataract Surgery Outcomes Study. Br J Ophthalmol. 1996 Aug;80(8):689-93.</citation>
    <PMID>8949710</PMID>
  </reference>
  <reference>
    <citation>Qatarneh D, Mathew RG, Palmer S, Bunce C, Tuft S. The economic cost of posterior capsule tear at cataract surgery. Br J Ophthalmol. 2012 Jan;96(1):114-7. doi: 10.1136/bjo.2010.200832. Epub 2011 Mar 1.</citation>
    <PMID>21362773</PMID>
  </reference>
  <reference>
    <citation>Chatoux O, Touboul D, Buestel C, Balcou P, Colin J. [Crystalline lens photodisruption using femtosecond laser: experimental study]. J Fr Ophtalmol. 2010 Sep;33(7):472-80. doi: 10.1016/j.jfo.2010.06.008. French.</citation>
    <PMID>20817344</PMID>
  </reference>
  <reference>
    <citation>Friedman NJ, Palanker DV, Schuele G, Andersen D, Marcellino G, Seibel BS, Batlle J, Feliz R, Talamo JH, Blumenkranz MS, Culbertson WW. Femtosecond laser capsulotomy. J Cataract Refract Surg. 2011 Jul;37(7):1189-98. doi: 10.1016/j.jcrs.2011.04.022. Erratum in: J Cataract Refract Surg. 2011 Sep;37(9):1742.</citation>
    <PMID>21700099</PMID>
  </reference>
  <reference>
    <citation>Palanker DV, Blumenkranz MS, Andersen D, Wiltberger M, Marcellino G, Gooding P, Angeley D, Schuele G, Woodley B, Simoneau M, Friedman NJ, Seibel B, Batlle J, Feliz R, Talamo J, Culbertson W. Femtosecond laser-assisted cataract surgery with integrated optical coherence tomography. Sci Transl Med. 2010 Nov 17;2(58):58ra85. doi: 10.1126/scitranslmed.3001305.</citation>
    <PMID>21084720</PMID>
  </reference>
  <reference>
    <citation>Masket S, Sarayba M, Ignacio T, Fram N. Femtosecond laser-assisted cataract incisions: architectural stability and reproducibility. J Cataract Refract Surg. 2010 Jun;36(6):1048-9. doi: 10.1016/j.jcrs.2010.03.027.</citation>
    <PMID>20494782</PMID>
  </reference>
  <reference>
    <citation>Taketani F, Matuura T, Yukawa E, Hara Y. Influence of intraocular lens tilt and decentration on wavefront aberrations. J Cataract Refract Surg. 2004 Oct;30(10):2158-62.</citation>
    <PMID>15474830</PMID>
  </reference>
  <reference>
    <citation>Nagy Z, Takacs A, Filkorn T, Sarayba M. Initial clinical evaluation of an intraocular femtosecond laser in cataract surgery. J Refract Surg. 2009 Dec;25(12):1053-60. doi: 10.3928/1081597X-20091117-04.</citation>
    <PMID>20000286</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2013</study_first_submitted>
  <study_first_submitted_qc>November 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2013</study_first_posted>
  <last_update_submitted>February 2, 2017</last_update_submitted>
  <last_update_submitted_qc>February 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cataract surgery</keyword>
  <keyword>femtosecond laser cataract surgery</keyword>
  <keyword>phacoemulsification</keyword>
  <keyword>Cost-Benefit Analysis</keyword>
  <keyword>Cost Effectiveness</keyword>
  <keyword>Hospital Costs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

